ANVS
Annovis Bio, Inc.
NYSE · Healthcare · Biotechnology · US
$1.39
+0.72%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- 4.40x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 0.38x
Liquidity & coverage
- Current ratio
- 2.95x
- Quick ratio
- 2.95x
- Cash ratio
- 2.95x
- Interest coverage
- -31.16x
- EBITDA / interest
- -30.88x
- Working capital
- $12.4M
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026